MétaCan
Menu
Back to cohort

Abstract PR-04: Targeting PRMT5 to modulate endogenous retroviruses expression in melanoma

2025· article· en· W4414465170 on OpenAlexaboutno aff
Simon Milette, Simon F. Roy, Veronica T. Brooks, K. Rachael Parks, Marcus Bosenberg, Richard A. Flavell, Goran Micevic

Bibliographic record

VenueCancer Immunology Research · 2025
Typearticle
Languageen
FieldBiochemistry, Genetics and Molecular Biology
TopicCancer-related gene regulation
Canadian institutionsnot available
Fundersnot available
KeywordsProtein arginine methyltransferase 5MelanomaHistoneImmune checkpointEpigeneticsBlockadeEndogenyImmune system

Abstract

fetched live from OpenAlex

Abstract Immune checkpoint blockade (ICB) is a mainstay of advanced melanoma treatment but often fails as a consequence of low tumor antigenicity and inadequate immune cell infiltration. Endogenous retroviruses (ERVs) are genomic proviral elements that are epigenetically repressed, in part, through histone modification. ERV re-activation can promote type I interferon (IFN) production and stimulate adaptive responses, which can increase tumor immunogenicity. However, therapeutic efforts to de-repress ERV expression have been hindered by a lack of clinical-grade epigenetic modulators. Protein arginine methyl transferase PRMT5 is a known epigenetic regulator of histone codes with selective and potent inhibitors. Recently, PRMT5 was implicated in the control of the cGAS/STING pathway, which senses cytosolic dsDNA proviral elements. Yet, it remains unclear whether PRMT5 can directly regulate ERV expression through histone methylation and whether it can be targeted to trigger cGAS/STING-IFN responses to augment anti-tumor immunity in melanoma. Here, we show that PRMT5 inhibition alone triggers type I IFN signaling in melanoma, which is mechanistically dependent on STING activity. In a syngeneic preclinical model of melanoma (YUMMER), PRMT5 inhibition acts synergistically with PD-1 blockade to markedly decrease cancer progression in a type I IFN-dependent manner. Spectral flow cytometric deconvolution of the melanoma immune landscape uncovered a significant shift in the lymphoid compartment linked to PRMT5 blockade, including an accumulation of a distinct CD4+PD-1+ICOShi T cell subset and changes to CD8+ T cell states. Importantly, in a syngeneic model of ICB-unresponsive melanoma, we show that PRMT5 inhibition synergizes with ICB to significantly impair tumor expansion in a type I IFN- and CD4+ T cell-mediated fashion. Finally, genomic analyses of primary human melanoma cell lines from the Yale SPORE program reveal that PRMT5 correlates with suppressed expression of discrete ERVs and IFN-stimulated response genes. Together, these findings point to PRMT5 as a direct regulator of ERV expression in melanoma and identify a novel epigenetic approach to augment adaptive anti-tumor immunity. Citation Format: Simon Milette, Simon F. Roy, Veronica T. Brooks, Koonam Parks, Marcus W. Bosenberg, Richard A. Flavell, Goran Micevic. Targeting PRMT5 to modulate endogenous retroviruses expression in melanoma [abstract]. In: Proceedings of the AACR Special Conference in Cancer Research: Mechanisms of Cancer Immunity and Cancer-related Autoimmunity; 2025 Sep 24-27; Montreal, QC, Canada. Philadelphia (PA): AACR; Cancer Immunol Res 2025;13(9 Suppl):Abstract nr PR-04.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame distilled prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.

metaresearch head score (Codex)0.001
metaresearch head score (Gemma)0.000
Version: codex-gemma-dda1882f352aValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Bench or experimental · Consensus signal: Bench or experimental
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.072
Threshold uncertainty score0.717

Codex and Gemma teacher scores by category

CategoryCodexGemma
Metaresearch0.0010.000
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0000.001
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0000.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.045
GPT teacher head0.359
Teacher spread0.315 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one teacher head, not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designBench or experimental
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2025
Admission routes1
Has abstractyes

Explore more

Same venueCancer Immunology ResearchSame topicCancer-related gene regulationFrench-language works237,207